Sarepta

Sarepta
We are focused on the development of precision genetic medicines to treat rare neuromuscular and central nervous system diseases. Learn more about Sarepta.
Gene Therapy
Drug Development
Clinical Research
Molecular Biology
Biostatistics
Open roles at Sarepta
10 open roles
Director, AI Architecture & Governance
Cambridge, MA
On-site
Director
Full-time
$206,000 - $257,500
6d ago
Duchenne Nurse Educator
Healthcare
3 Locations
On-site
Mid Level
Full-time
$136,000 - $170,000
2 weeks ago
Senior Manager, Corporate Quality – R&D Audits
QA
Bedford, MA
On-site
Senior
Full-time
$136,000 - $170,000
2 weeks ago
Director, Biostatistics
United States
On-site
Director
Full-time
$206,000 - $257,500
2 weeks ago
Senior Neuromuscular Clinical Sales Specialist - Atlantic
Sales
4 Locations
On-site
Senior
Full-time
$173,200 - $216,500
4 weeks ago
Senior Director, Product Development, RNA Therapies
2 Locations
On-site
Director
Full-time
$222,400 - $278,000
1 month ago
Director, Patient Focused Drug Development and Innovation
Cambridge, MA
On-site
Director
Full-time
$185,600 - $232,000
1 month ago
Scientist-II Developability & Preformulation
Columbus, OH
On-site
Mid Level
Full-time
$106,400 - $133,000
1 month ago
MSL Team Lead - US East
4 Locations
On-site
Lead
Full-time
$206,000 - $257,500
1 month ago
Manager, International Business
Cambridge, MA
On-site
Lead
Full-time
1 month ago
Closed positions
19 positions
Sr. Manager, Corporate Quality - GCP
2 Locations
Senior
Closed 5d ago
Associate Director, Biomarker Science
United States
Director
Closed 1 week ago
Senior Manager, R&D Training System & Operations
United States
Senior
Closed 1 week ago
Senior AI/ML Engineer
Cambridge, MA
Senior
Closed 1 week ago
Quality Control Analyst (Sun-Wed shift)
Andover, MA
Mid Level
Closed 1 week ago
Products and services

EXONDYS 51
Antisense Oligonucleotide
EL
ELEVIDYS
Gene Therapy
VY
Vyondys 53
Antisense Oligonucleotide

VILTEPSO
Antisense Oligonucleotide
AM
Amondys 45
Antisense Oligonucleotide
LI
Limb-girdle Muscular Dystrophy Programs
Gene Therapy
SR
SRP-9001
Gene Therapy
CA
CASIMERSEN
RNA-targeted Therapy
CH
Charcot-Marie-Tooth Disease Programs
Neuromuscular Therapy
SR
SRP-5051
Antisense Oligonucleotide

RNA-targeted therapeutics platform
Platform Technology
Similar companies
Illumina
Illumina sequencing and array technologies drive advances in life science research, translational and consumer genomics, and molecular diagnostics.
San Diego, San Diego County
5,001-10,000 employees
Public
Valuation $36.0B
107 open jobs

Grail
GRAIL is a healthcare company pioneering new technologies to advance early cancer detection. Discover our mission to detect cancer early, when it can be cured.
Menlo Park, California founded
201-500 employees
Private
Valuation $3.2B
30 open jobs

Insitro
Machine learning-powered drug discovery and development
South San Francisco, CA
201-500 employees
Private
Valuation $2.4B
12 open jobs

CRISPR Therapeutics
CRISPR Therapeutics AG is a Swiss–American biotechnology company headquartered in Zug, Switzerland. The company does business as CRISPR Therapeutics, Inc. in…
Zug, Canton of Zug
201-500 employees
Public
Valuation $2.9B
13 open jobs

Ginkgo Bioworks
Ginkgo Bioworks develops autonomous labs for biotechnology, enabling scientists to program biology and accelerate R&D through cloud lab services and…
Boston, Suffolk County
501-1,000 employees
Public
Valuation $2.5B
17 open jobs
Latest updates
All
X
News
HN
YouTube
Sarepta Therapeutics (SRPT) Stock Analysis: Navigating the Biotech Landscape with Innovative Therapies - DirectorsTalk Interviews
DirectorsTalk Interviews
News
·
2d ago
Sarepta Therapeutics Faces Investor Investigations – 8-5 - stl.news
stl.news
News
·
4d ago
Law firm probes Sarepta Therapeutics over deaths linked to Elevidys gene therapy risks. - Pluang
Pluang
News
·
4d ago
Sarepta Therapeutics Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Sarepta Therapeutics, Inc. - SRPT - PR Newswire
PR Newswire
News
·
4d ago
Why Is Sarepta Therapeutics (SRPT) Up 37% Since Last Earnings Report? - Yahoo Finance
Yahoo Finance
News
·
4d ago
Show 15 more
Total Views
10
Total Apply Clicks
0
Total Mock Apply
0
Total Bookmarks
0
Reviews
3.7
10 reviews
Work-life balance
3.2
Compensation
2.8
Culture
4.1
Career
3.4
Management
2.5
65%
Recommend to a friend
Pros
Supportive and collaborative team environment
Cutting-edge research and innovative projects
Good work-life balance and flexible hours
Cons
Below industry standard salary and underpaid entry-level positions
Lack of direction from management
High stress and overwhelming expectations
Salary Ranges
56 data points
Director
3 reports
-
total per year
Base
$187,500
Stock
-
Contact and location